Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | 0.00% | -0.53% | -16.44% |
Mar. 29 | TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 06 | Knight Therapeutics Announces Launch of Bijuva in Canada | MT |
Financials (USD)
Sales 2022 | 69.96M | Sales 2023 | 1.3M | Capitalization | 25.77M |
---|---|---|---|---|---|
Net income 2022 | 112M | Net income 2023 | -10M | EV / Sales 2022 | 0.34 x |
Net cash position 2022 | 29.31M | Net Debt 2023 | 3.68M | EV / Sales 2023 | 22.6 x |
P/E ratio 2022 |
0.47
x | P/E ratio 2023 |
-2.28
x | Employees | 1 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.22% |
1 week | -0.53% | ||
Current month | -17.90% | ||
1 month | -17.90% | ||
3 months | -17.90% | ||
6 months | -12.15% | ||
Current year | -16.44% |
Managers | Title | Age | Since |
---|---|---|---|
Marlan Walker
CEO | Chief Executive Officer | 50 | 13-05-31 |
Joseph Ziegler
DFI | Director of Finance/CFO | - | 23-08-16 |
Corporate Officer/Principal | - | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tommy Thompson
CHM | Chairman | 81 | 12-04-15 |
Cooper Collins
BRD | Director/Board Member | 45 | 12-02-27 |
Gail Naughton
BRD | Director/Board Member | 69 | 20-03-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 1.88 | +1.08% | 19,137 |
24-04-19 | 1.86 | -1.59% | 10,363 |
24-04-18 | 1.89 | 0.00% | 5,739 |
24-04-17 | 1.89 | -0.53% | 29,032 |
24-04-16 | 1.9 | -2.56% | 45,679 |
Delayed Quote Nasdaq, April 23, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-16.44% | 21.68M | |
+11.37% | 9.18B | |
-16.33% | 4.78B | |
+6.40% | 3.87B | |
+26.98% | 3.73B | |
+28.27% | 2.52B | |
-26.55% | 2.27B | |
-25.02% | 2.21B | |
+5.82% | 1.95B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- TXMD Stock